Group B streptococci, GBS, a gram-positive bacterium, usually planted in the lower reproductive tract and gastrointestinal tract, but also in the upper respiratory tract of infants. It was first discovered in the 1960s that it can cause severe neonatal infection. Subsequently, a large number of studies were carried out, and it was found that group B streptococcus was the first pathogenic bacterium in perinatal infection, which could lead to perinatal death. It is also an important pathogen of maternal reproductive tract infection. Between 10 and 30 percent of pregnant women are infected with GBS, and between 40 and 70 percent of them are transmitted to newborns during childbirth. About 1 to 3 percent of the newborns will develop the disease, once the incidence of neonatal mortality is as high as 26 to 50 percent. The rate of preterm birth in GBS positive pregnant women is as high as 60%. The incidence of premature rupture of membranes was 35%.
It provides diagnosis for that treatment of the precursor abortion and the basis for the treatment
Increased the positive rate of routine screening to avoid missed diagnosis and avoid disputes between doctors and patients
Extend gestational weeks, increase fetal survival rate and quality of life, reduce maternal and infant infection rate and complications
Effectively guide the use of antibiotics in pregnant women and newborns to avoid the abuse of antibiotics
Rapid detection of antenatal high - risk symptoms and make timely diagnosis
Chemtron biotech otc rapid strep test
is of high quality. Learn more about the otc rapid strep test from chemtron biotech